GgoogleDE first seen 7 d ago, last 3 d ago, peak #1
Bayer raises annual targets after quarterly results
Original: bayer aktie
Bayer lifted its full-year targets following its quarterly results, with chief executive Bill Anderson describing a 'turning point' for the German pharmaceutical and chemicals group. Attention is also on the blood-thinner drug asundexian, which is now seen as a key hope for the company after earlier troubles. Analyst firm Jefferies, however, maintains a 'Hold' rating on Bayer shares.
Why now: Bayer's upgraded guidance and its turnaround prospects are moving the share price and investor sentiment.
BayerBill AndersonJefferiesasundexian
Rank over time, top of the chart is #1. 5 snapshots from 3 d ago to 3 d ago.
Evidence
- Glyphosat: Bayer gewinnt weiteren Prozess in Missouri · top agrar
- Quartalsergebnis: Bayer hebt die Jahresziele an – Konzernchef sieht „Wendepunkt“ · Handelsblatt
- JEFFERIES stuft BAYER AG auf 'Hold' · Wallstreet Online
- Asundexian: Vom Sorgenkind zu Bayers Hoffnungsträger · FAZ
API: https://socialmediatrends-api.osmike.com/v1/trends/4215269